Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New consortium to make UK a world leader in AI drug discovery

A new consortium, co-led by NDM researchers, has just been announced, aiming to make the UK a leader in artificial intelligence-driven drug discovery. The ‘OpenBind’ consortium will slash the cost of drug discovery and development by as much as £100 billion.

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.

Malaria vaccine wins Galien Foundation prize for Best Public Sector Innovation

The R21/Matrix-M malaria vaccine has received the Galien Foundation prize for Best Public Sector Innovation. Members of the Jenner Institute team, Prof Sir Adrian Hill, Mehreen Datoo and Lisa Stockdale were present during the Galien Foundation UK Forum & Awards Ceremony in London on 05 June 2025.

Study highlights effectiveness of neuromodulatory therapy on severe epileptic focal seizures

A long-term clinical study has confirmed the effectiveness of a neuromodulatory treatment for severe focal seizures in both children and adults with drug-resistant epilepsy (DRE) and demonstrated the therapy’s lasting impact.

New research identifies key driver of inflammation in spondyloarthritis

NDORMS researchers have identified a primary source of inflammatory IL-17 driving spondyloarthritis, paving the way for the development of targeted therapies to treat the condition.

The Pandemic Sciences Institute publishes first validated tool to measure stigma during disease outbreaks

Researchers at the Pandemic Sciences Institute have published RAPID Stigma Scales to help health professionals monitor stigma in disease outbreak settings, improving outbreak responses globally.

Maternal obesity is associated with increased risk of hospital admission for infection in children

A new study by researchers at Oxford Population Health’s National Perinatal Epidemiology Unit has found that children born to mothers with a body mass index (BMI) of 35 or above may have an increased risk of being admitted to hospital for an infection. The study is published in BMJ Medicine.

Unlocking the potential of genetic data for research and healthcare

A team of scientists and engineers who analyse and curate the world’s largest genetic datasets have announced a new data format designed to unlock the potential of the millions of genomes now sequenced in healthcare systems around the world.

Global Surgery alumnus publishes key study on neonatal surgical services in Bangladesh

Congratulations to Dr Md Sharif Imam, an alumnus of the Oxford University Global Surgery Group, on the recent publication of his paper in the Journal of Paediatric Surgeons of Bangladesh.

New method provides the key to accessing proteins in ancient human remains

A new method developed by researchers at the Nuffield Department of Medicine, University of Oxford, could soon unlock the vast repository of biological information held in the proteins of ancient soft tissues. The findings, which could open up a new era for palaeobiological discovery, have been published this week in PLOS ONE.

New Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science study looking for a breakthrough in osteosarcoma

The Bone Cancer Research Trust and Sarcoma UK are joining forces to launch two groundbreaking research projects which could support the early diagnosis of primary bone cancer.

Project to develop low-cost genome sequencing for pathogens launched

A low-cost genome sequencing technique that was used by thousands of laboratories globally to spot COVID-19 variants will be extended to cover all pathogens, in an ambitious new Wellcome Trust-funded project launched today. The ARTIC-2 project is led by the University of Birmingham and brings together researchers from the Democratic Republic of Congo, Ghana and Kenya with expertise in responding to numerous viral threats using genomic surveillance, including recent outbreaks of Ebola virus and Mpox in Africa.

Having two or more long-term health conditions is associated with poorer brain health

People living with two or more long-term health conditions are more likely to have poorer brain health, according to a new study by researchers at Oxford Population Health.

From conversation to collaboration: Departments tackle shared health challenges

Researchers from our department and the Department of Psychiatry came together last week for a collaborative showcase, aiming to spark new ideas for collaborative research by identifying areas of shared interest and potential.

New paper explores how the immune system fails in CASPR2-antibody encephalitis

The findings shed new light on how the body’s own defenses can mistakenly turn against the brain - and potentially opens the door to more targeted treatments.

Team presents Headline Data at the World Congress on Endometriosis in Sydney

Dr Tatjana Gibbons, an investigator on the ongoing DETECT study, presented results at the World Congress on Endometriosis 2025. The study aims to determine the feasibility of detecting endometriosis using 99mTc-maraciclatide and single-photon emission computed tomography.

Academy of Medical Sciences elects five Oxford researchers as new Fellows

The Academy of Medical Sciences has elected five University of Oxford biomedical and health scientists to its fellowship in 2025.

Eight Oxford Scientists Elected Fellows of the Royal Society

Eight distinguished academics from the University of Oxford have been elected Fellows of the Royal Society, the UK’s national academy of sciences, in recognition of their exceptional contributions to science.

Medical Sciences celebrates success at Vice-Chancellor’s Awards 2025

The winners of the 2025 Vice-Chancellor’s Awards were announced at a special ceremony hosted by the Vice-Chancellor in the Sheldonian Theatre on Thursday 15 May.

The new Pandemic Agreement offers a glimmer of hope that no country will face future pandemic threats alone

Professor Alice Norton reflects on what the new Pandemic Agreement means for global health security.

Load More